Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Sumitomo Dainippon Pharma
Sumitomo Dainippon Pharma inks deal for VR-based DTx with BehaVR
By
Adam Ang
|
02:34 am |
October 21, 2021
They will develop and commercialise three novel digital therapeutic products.
